SFX by Ex Libris Inc.

Title:	Follow-up investigation of 12 proposed linkage regions in multiple sclerosis
Source:	Genes and Immunity [1466-4879] Herrera, B M yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zennaro, Xavier C. "Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism." Human mutation 28.1 (2006): 33-40.
description	2.	Biró, E. "Association of systemic and thyroid autoimmune diseases." Clinical rheumatology 25.2 (2006): 240-5.
description	3.	Dyment, George C A. "Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance." Human Molecular Genetics 14.14 (2005): 2019-26.
description	4.	ALEXANDER, Richard B B. "GRANULOMATOUS PROSTATITIS LINKED TO HLA-DRB1*1501." The Journal of urology 171.6 (2004): 2326-2329.
description	5.	Chataway, J. "The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen." Brain 121.part 10 (1998): 1869-1887.
description	6.	Fernandes-Rosa, Fabio L L. "Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene." The Journal of clinical endocrinology & metabolism 91.9 (2006): 3671-5.
description	7.	Balsamo A, Cicognani A, Gennari M, Sippell WG, Men, Felix G G. "Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1." European journal of endocrinology 156.2 (2007): 249-56.
description	8.	Hsueh, C. "Mycobacterium abscessus Granulomatous Prostatitis." The American journal of surgical pathology 36.3 (2012): 418-22.
description	9.	Lovelace, R. "Assessing the energy implications of replacing car trips with bicycle trips in Sheffield, UK." Energy policy 39.4 (2011): 2075-2087.
description	10.	Pirko, I. "The relevance of animal models in multiple sclerosis research." Pathophysiology 18.1 (2010): 21-29.
description	11.	[Anon]. "Genome-wide association study in multiple sclerosis identifies novel non-MHC risk alleles." Journal of neurology, neurosurgery and psychiatry 79.3 (2008): 345-345.
description	12.	Slotema, Christina W. "Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders." The journal of clinical psychiatry 71.7 (2010): 873-84.
description	13.	Zollner, Thomas M. "Techniques: species' finest blend--humanized mouse models in inflammatory skin disease research." Trends in Pharmacological Sciences 25.10 (2004): 543-9.
description	14.	Stegbauer, J. "Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system." Proceedings of the National Academy of Sciences of the United States of America 106.35 (2009): 14942-14947.
description	15.	Haines, JL. "A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex." Nature genetics 13.4 (1996): 469-471.
description	16.	Goodin, Douglas S. "The causal cascade to multiple sclerosis: a model for MS pathogenesis." PloS one 4.2 (2009).
description	17.	Brynedal, J. "HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis." PLOS One 2.7 (2007).
description	18.	Zennaro, M C C. "Human mineralocorticoid receptor genomic structure and identification of expressed isoforms." The Journal of biological chemistry 270.36 (1995): 21016-20.
description	19.	Pitzalis, M. "Genetic loci linked to Type 1 Diabetes and Multiple Sclerosis families in Sardinia." BMC medical genetics 9.1 (2008): 3-3.
description	20.	Huong, D L L. "Urogenital manifestations of Wegener granulomatosis." Medicine 74.3 (1995): 152-61.